Australia markets closed

Bioventus Inc. (BVS)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
4.8100-0.1600 (-3.22%)
At close: 04:00PM EDT
4.7808 -0.03 (-0.61%)
After hours: 04:07PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 305.49M
Enterprise value 663.37M
Trailing P/E N/A
Forward P/E 40.16
PEG ratio (5-yr expected) N/A
Price/sales (ttm)0.59
Price/book (mrq)2.20
Enterprise value/revenue 1.29
Enterprise value/EBITDA -28.75

Trading information

Stock price history

Beta (5Y monthly) 0.48
52-week change 3353.77%
S&P500 52-week change 325.65%
52-week high 36.0800
52-week low 30.8600
50-day moving average 34.9360
200-day moving average 34.1280

Share statistics

Avg vol (3-month) 3140.33k
Avg vol (10-day) 3115.19k
Shares outstanding 563.38M
Implied shares outstanding 663.38M
Float 823.2M
% held by insiders 115.53%
% held by institutions 166.30%
Shares short (15 Mar 2024) 4808.24k
Short ratio (15 Mar 2024) 44.92
Short % of float (15 Mar 2024) 42.06%
Short % of shares outstanding (15 Mar 2024) 41.02%
Shares short (prior month 15 Feb 2024) 4835.06k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023


Profit margin -30.49%
Operating margin (ttm)1.91%

Management effectiveness

Return on assets (ttm)0.12%
Return on equity (ttm)-38.27%

Income statement

Revenue (ttm)512.34M
Revenue per share (ttm)8.18
Quarterly revenue growth (yoy)7.60%
Gross profit (ttm)N/A
Net income avi to common (ttm)-96.74M
Diluted EPS (ttm)-1.5400
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)36.96M
Total cash per share (mrq)0.58
Total debt (mrq)420.62M
Total debt/equity (mrq)190.23%
Current ratio (mrq)1.53
Book value per share (mrq)2.74

Cash flow statement

Operating cash flow (ttm)15.34M
Levered free cash flow (ttm)-108.45M